Skip to content

Stimulus-response and Parkinson's Disease (SRlearning)

Stimulus-response Associations in Parkinson's Disease Patients

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02515136
Acronym
SRlearning
Enrollment
100
Registered
2015-08-04
Start date
2015-07-01
Completion date
2018-01-31
Last updated
2019-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Brief summary

In a computerized experiment, visual stimuli will be presented to the parkinson's disease patients and to the controls. They will respond to each image by acting on the keyboard in a specific manner. Each participant will repeat that task 384 times per session. A break will be inserted every 12 tests so that participants can rest. The experiment consists of three sessions. Each image will be presented three times. For the first two presentations it is assumed that a link will be created between the image and the task, and the image and action. In the third presentation, the same task and the same action will be maintained or will be swapped. In this way, It can be checked whether associations thus generated will affect the performance of the participants when tasks and actions will be incongruent.

Interventions

BEHAVIORALStimulus-response

See summary

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient : Parkinson's disease Controls: healthy volunteers paired to patients on sex and age group

Exclusion criteria

* Other neurological condition * Known pregnancy or breastfeeding woman * No medical insurance coverage * Person under legal protection

Design outcomes

Primary

MeasureTime frame
Reaction time (second)immediate

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026